{
    "2018-08-17": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Should you trade or fade this week's biggest winners?",
                "features": {
                    "keywords": [
                        "trade",
                        "fade",
                        "biggest winners"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Lilly (LLY) Hits 52-Week High, Can the Run Continue?",
                "features": {
                    "keywords": [
                        "Lilly",
                        "LLY",
                        "52-Week High",
                        "Run Continue"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Bayer",
                        "FDA",
                        "MRK",
                        "Cancer Drug",
                        "New Indication"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Aveo",
                        "Stock Offering",
                        "FDA",
                        "Generic EpiPen",
                        "Pfenex",
                        "Exec Resigns"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}